SE9803760D0 - Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel - Google Patents

Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel

Info

Publication number
SE9803760D0
SE9803760D0 SE9803760A SE9803760A SE9803760D0 SE 9803760 D0 SE9803760 D0 SE 9803760D0 SE 9803760 A SE9803760 A SE 9803760A SE 9803760 A SE9803760 A SE 9803760A SE 9803760 D0 SE9803760 D0 SE 9803760D0
Authority
SE
Sweden
Prior art keywords
cei
restless legs
legs syndrome
sleep
diagnose
Prior art date
Application number
SE9803760A
Other languages
English (en)
Inventor
Jan Edner
Holger Kraiczi
Original Assignee
Jan Hedner
Holger Kraiczi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Hedner, Holger Kraiczi filed Critical Jan Hedner
Priority to SE9803760A priority Critical patent/SE9803760D0/sv
Publication of SE9803760D0 publication Critical patent/SE9803760D0/sv
Priority to EP99957453A priority patent/EP1154795B1/en
Priority to DE69926804T priority patent/DE69926804T2/de
Priority to PCT/SE1999/001979 priority patent/WO2000025821A1/en
Priority to ES99957453T priority patent/ES2251242T3/es
Priority to DK99957453T priority patent/DK1154795T3/da
Priority to AT99957453T priority patent/ATE302025T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
SE9803760A 1998-11-04 1998-11-04 Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel SE9803760D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9803760A SE9803760D0 (sv) 1998-11-04 1998-11-04 Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
EP99957453A EP1154795B1 (en) 1998-11-04 1999-11-03 Means for treating and diagnosing restless legs syndrome
DE69926804T DE69926804T2 (de) 1998-11-04 1999-11-03 Vorrichtungen zur behandlung und diagnose des restless leg syndroms
PCT/SE1999/001979 WO2000025821A1 (en) 1998-11-04 1999-11-03 Method of treating and diagnosing restless legs syndrome and corresponding means
ES99957453T ES2251242T3 (es) 1998-11-04 1999-11-03 Medio para tratar y diagnosticar el sindrome de piernas inquietas.
DK99957453T DK1154795T3 (da) 1998-11-04 1999-11-03 Middel til behandling af diagnosticering af restless legs syndrom
AT99957453T ATE302025T1 (de) 1998-11-04 1999-11-03 Vorrichtungen zur behandlung und diagnose des restless leg syndroms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803760A SE9803760D0 (sv) 1998-11-04 1998-11-04 Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel

Publications (1)

Publication Number Publication Date
SE9803760D0 true SE9803760D0 (sv) 1998-11-04

Family

ID=20413169

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803760A SE9803760D0 (sv) 1998-11-04 1998-11-04 Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel

Country Status (7)

Country Link
EP (1) EP1154795B1 (sv)
AT (1) ATE302025T1 (sv)
DE (1) DE69926804T2 (sv)
DK (1) DK1154795T3 (sv)
ES (1) ES2251242T3 (sv)
SE (1) SE9803760D0 (sv)
WO (1) WO2000025821A1 (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2241458C2 (ru) 1997-12-22 2004-12-10 Эро-Селтик, С.А. Комбинации агонист/антагонист опиоида
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
DE19938823A1 (de) * 1999-08-19 2001-02-22 Boehringer Ingelheim Pharma Medikamentöse Behandlung des Restless Leg Syndroms
AU2002241326B2 (en) 2001-03-30 2007-09-06 Toray Industries, Inc Remedies for psychoneurosis
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
ES2546010T3 (es) 2002-04-05 2015-09-17 Euro-Celtique S.A. Preparación farmacéutica que contiene oxicodona y naloxona
US6960571B2 (en) 2003-03-14 2005-11-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
WO2005016327A2 (en) * 2003-08-13 2005-02-24 Janssen Pharmaceutica, N.V. Treatment of sleep disorders with cholinesterase inhibitors
KR20070085033A (ko) 2003-10-21 2007-08-27 코루시드 파마슈티컬즈 인코포레이티드 콜린에스테라제를 억제하고 약리 활성제를 방출하는카르바모일 에스테르
DK1742624T3 (da) * 2004-02-18 2010-03-08 Sepracor Inc Dopamin-agonist-kombinationsterapi med sedativer til forbedring af søvnkvalitet
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1891946A1 (en) * 2006-08-14 2008-02-27 Santhera Pharmaceuticals (Schweiz) AG Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone
AU2008214380A1 (en) 2007-02-02 2008-08-14 Colucid Pharmaceuticals, Inc. Compounds that inhibit cholinesterase
EP2182938A2 (en) * 2007-07-18 2010-05-12 Colucid Pharmaceuticals, Inc. Methods for promoting wakefulness
SG174286A1 (en) 2009-03-10 2011-10-28 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
EP2251010A1 (en) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Use of thiabendazole and derivatives thereof for the therapy of neurological conditions
CA2790164A1 (en) 2010-02-17 2011-08-25 Sun Pharma Advanced Research Company Ltd. Method of treating a disease condition susceptible to baclofen therapy
NZ716267A (en) 2013-07-23 2017-05-26 Euro Celtique Sa A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO274596A0 (en) * 1996-10-04 1996-10-31 Armstrong, Stuart Maxwell Method for the treatment of neurological or neuropsychiatric disorders
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms

Also Published As

Publication number Publication date
WO2000025821A1 (en) 2000-05-11
ES2251242T3 (es) 2006-04-16
ATE302025T1 (de) 2005-09-15
DE69926804T2 (de) 2006-06-22
DK1154795T3 (da) 2006-01-02
EP1154795B1 (en) 2005-08-17
DE69926804D1 (de) 2005-09-22
EP1154795A1 (en) 2001-11-21

Similar Documents

Publication Publication Date Title
SE9803760D0 (sv) Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
DK0668863T3 (da) Quinuclidinderivat som substans P-antagonist
BR0111980A (pt) Amina substituìda, composto protegido, métodos para tratar um paciente que tenha ou para prevenir que um paciente contraia uma doença ou condição, para inibir a atividade da beta-secretase, para inibir a clivagem da proteìna precursora de amilóide (app), para inibir a produção do peptìdeo beta amilóide (a beta) em uma célula, para inibir a produção de placa beta0amilóide em um animal, e para tratar ou prevenir uma doença compreendendo depósitos de beta-amilóide no cérebro, composição método para produzir um complexo de beta-secretase, conjunto, e, uso de amina substituìda
EA200200208A1 (ru) Синергитическая композиция
BR0211119A (pt) Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
EA199800626A1 (ru) Применение агониста ppar-гамма для лечения синдрома х
NO20042964L (no) Spiroazasykliske forbindelser som monoaminreseptormodulatorer
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
NO20024646L (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
DK1296972T3 (da) Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer
ATE180781T1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
SE0201713D0 (sv) New methods and use III
DK0946162T3 (da) Anvendelse af p-aminophenol-derivater til fremstilling af farmaceutiske præparater, som er nyttige til behandlingen af neurodegenerative sygdomme
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
MXPA02012730A (es) Uso de acido pamoico o uno de sus derivados o uno de sus analogos para la preparacion de un medicamento para el tratamiento de enfermedades caracterizadas por depositos de agregados de amiloide.
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
SE0004101D0 (sv) New use
EA200400302A1 (ru) Способ лечения первичной бессонницы
FR2690847B1 (fr) Compositions a activite agoniste des recepteurs analogues a 5ht1 selective.
SE9902387D0 (sv) New pharmaceutically active compounds
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
CO4940453A1 (es) Nuevo metodo de tratamiento con agente antihiperglucemicos inhibidores de alfaglucosida- sa para tratamiento de diabetes